F13.121
Sedative, hypnotic or anxiolytic abuse with intoxication delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F13.121 describes a medical condition where an individual misuses sedative, hypnotic, or anxiolytic medications, leading to a state of intoxication and delirium. These medications are often prescribed for anxiety, sleep disorders, or sedation but can be misused or abused, resulting in serious health complications. Recognizing the features of this condition is essential for prompt identification and management, especially considering the potential for severe neurological effects associated with intoxication delirium.
Causes & Symptoms
Clinical Causes: Misuse or intentional abuse of prescribed sedative, hypnotic, or anxiolytic medications Self-medication without medical supervision Attempt to enhance sedative effects or alleviate anxiety through increased doses Substance dependence leading to increased consumption Combination of sedatives with other central nervous system depressants such as alcohol
Key Symptoms: Altered mental state, including confusion or disorientation Hallucinations or delusional thinking Severe agitation or restlessness Altered consciousness, including somnolence or coma in extreme cases Impaired coordination and muscle weakness Fluctuating levels of alertness Visual disturbances Potential seizures or convulsions Physical signs such as decreased respiratory rate, hypotension, or cyanosis Emotional disturbances like anxiety, paranoia, or agitation
Diagnostic & Treatment
Diagnosis Path: Diagnosis is based on a comprehensive clinical assessment, including detailed patient history focusing on medication use and potential substance abuse. Healthcare providers may perform physical examinations and neurological assessments. Laboratory tests, such as blood or urine toxicology screens, can detect the presence of sedative, hypnotic, or anxiolytic substances. Differential diagnoses might include other causes of delirium, such as infections, metabolic disturbances, or neurological conditions. Accurate diagnosis relies on correlating clinical findings with toxicology results and understanding the context of medication misuse.
Treatment Protocols: Management typically involves supportive care to stabilize vital functions, such as maintaining airway, breathing, and circulation. Discontinuing or reducing the intake of offending medications is crucial. In some cases, detoxification protocols or medication-assisted treatment may be necessary to manage withdrawal symptoms. Monitoring for and treating complications like dehydration, hypoxia, or seizures are vital. Psychological support, counseling, and addiction treatment programs are often recommended to address underlying substance use issues. Long-term strategies involve patient education about medication risks and relapse prevention.
Clinical Advice & FAQs
Billing Guidance
Is F13.121 a billable ICD-10 code?
Yes, F13.121 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.121?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with intoxication delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference